Aharon Tsaturyan

Aharon Tsaturyan, MD – Editor, OncoDaily Intelligence Unit | Oncology Resident | Research Fellow at IMMONC

Aharon Tsaturyan, MD, is an oncology resident, medical editor, and researcher working at the intersection of clinical oncology, scientific communication, cancer awareness, and rare cancer research. He has been part of OncoDaily since September 2024 and currently serves as an Editor at the OncoDaily Intelligence Unit, where he focuses on evidence-based oncology storytelling that makes complex cancer topics accurate, engaging, and accessible to both professional and general audiences.

At OncoDaily, his editorial work spans several major content areas, including OncoLibrary, Celebrities and Cancer, Community Oncology, and Public Health. He also contributes to disease- and specialty-focused sections including OncoDaily IO, GI, Breast, and Lung.

A significant part of his work centers on OncoMyths and OncoFacts, celebrity cancer journeys, historical cancer cases, cancer-related charities and advocacy initiatives, public-awareness campaigns, health trends, and culturally relevant stories that bring oncology into broader public conversation. His work frequently uses real-world stories and recognizable public figures to raise awareness about cancer prevention, diagnosis, treatment, survivorship, and the lived experience of patients.

Dr. Tsaturyan is the author of several of OncoDaily’s most-read and high-performing articles, reflecting his ability to identify topics that combine medical relevance with strong public interest. His editorial approach blends scientific interpretation with accessible storytelling, helping complex oncology themes reach broader audiences without losing their clinical context.

Beyond OncoDaily, he has also contributed to international cancer media. He is the author of “From Oceans to Organs: The Alarming Cancer Risks of Microplastics,” published in Cancer World, exploring concerns around microplastic exposure, human health, and potential cancer-related risks.

Alongside his editorial work, Dr. Tsaturyan is an oncology resident at Yerevan State Medical University after Mkhitar Heratsi and works clinically at Mikayelyan University Hospital in Yerevan, Armenia. His clinical experience includes the evaluation and management of oncology patients in both inpatient and outpatient settings, participation in multidisciplinary tumor boards, and treatment planning under supervision. As part of his residency training, he is involved in the administration and monitoring of chemotherapy, targeted therapies, and immunotherapy, as well as the management of treatment-related toxicities and oncologic emergencies. He also provides patient and family education and contributes to coordinated, multidisciplinary cancer care.

He is also a Research Fellow at IMMONC, where his interests include rare and underrepresented cancers, global oncology, and cancer research disparities. He contributes to the Cardiac Angiosarcoma International Registry (CAIR), the BPDCN Registry Working Group, and IMMONC’s GI Cancer Scientific Group, while also supporting clinical research projects and ongoing clinical trials conducted through IMMONC. His research involvement reflects a broader commitment to strengthening evidence generation, expanding research opportunities, and increasing visibility for rare and underserved malignancies.

Dr. Tsaturyan is a co-author of the ASCO 2025 abstract “Global Inequities in Sarcoma Clinical Trials: A Comprehensive Analysis Over the Last Decade,” published in the Journal of Clinical Oncology meeting supplement. This work reflects his interest in global disparities in cancer research, equitable access to clinical trials, and the representation of underserved populations in oncology studies.

His involvement in academic governance began during medical school. As a student at Yerevan State Medical University, Dr. Tsaturyan served as a student member of the university’s Scientific Committee, contributing the student perspective to discussions on faculty appointments, scientific programs, and academic opportunities for students.

Dr. Tsaturyan received his MD in General Medicine from Yerevan State Medical University in 2024 and subsequently entered oncology residency training. His professional interests include medical and scientific communication, cancer awareness, public health, rare cancer epidemiology, global oncology, clinical research, patient advocacy, and the translation of oncology knowledge into clear, meaningful, and widely accessible public-facing content.